Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$389,070
+$19,417 QoQ
Shares Held
7,425
-29.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#265
of 421 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $29,351,232 across 10 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
885,796 | $14,066,440 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
12,119 | $6,566,437 | |
| 3 | ZTS |
Zoetis Inc.
|
51,264 | $3,683,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
17,488 | $2,947,427 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,884 | $843,069 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
24,309 | $389,673 | |
| 7 | ALKS |
Alkermes plc.
This page
|
7,425 | $389,070 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
23,253 | $336,935 |
All Filings in ALKS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $389,070 | 7,425 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $369,653 | 10,454 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $339,677 | 12,140 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $493,680 | 16,456 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $497,356 | 17,384 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $576,529 | 17,460 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $406,781 | 14,144 | Shares | Sole | 2026-08-21 | |
| 2024-09-30 | $284,322 | 10,158 | Shares | Sole | 2026-08-21 | |
| 2024-06-30 | $202,126 | 8,387 | Shares | Sole | 2026-08-21 | |
| 2024-03-31 | $809,014 | 29,886 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $693,361 | 24,995 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $709,745 | 25,339 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $806,945 | 25,781 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $746,612 | 26,485 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $714,159 | 27,331 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $496,820 | 22,249 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $561,601 | 18,852 | Shares | Sole | 2022-08-08 | |
| No filing history on record for this holder in this stock. | ||||||